TrialClinical lymphoma, myeloma & leukemia2017

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma.

Joseph J Maly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.